Vertex Pharmaceuticals · 23 hours ago
Associate Director, Pain Strategic Brand Analytics
Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. They are seeking an Associate Director, Pain Strategic Brand Analytics to provide analytics support for strategic initiatives and to collaborate with various stakeholders to enhance analytics capabilities in the Commercial organization.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Work with the Director, Pain Performance Analytics & Forecasting and Pain BU stakeholders to identify existing or planned initiatives that would benefit from additional analytics support, and collaboratively create analytics plans to deliver required insights
Develop & continuously improve framework for establishing goals and measuring execution pull-through of new wins (e.g. new hospital formulary approvals); present performance against goals during commercial performance meetings
Design & operate an analytical engine to identify & quantify drivers, barriers, and opportunities in the market using advanced statistical / ML methodology; synthesize findings for business stakeholders on a regular basis for evaluation & action
Contribute to answering ad-hoc analytics questions as they arise from the BU; work with BU stakeholders to understand their questions and most appropriate data & analytics approach
Serve as an internal team SME to elevate analytics capabilities within the Forecasting, Analytics, and Market Research team through existing expertise and ongoing self-education of best-in-class approaches
Work collaboratively with cross functional stakeholders including but not limited to US Marketing, Global Marketing, US Market Access, US Finance, Commercial Sales Operations, etc
Qualification
Required
Bachelor's degree in quantitative discipline required (e.g., Engineering, Statistics, Economics, Finance, Business Analytics) or equivalent experience
7-10 years of experience in the pharmaceutical or biotech industry, 6+ years of insights, analytics and/or reporting is required
Proficiency with complex modeling and analyzing and developing insights from large data sets, leveraging relevant tools such as SQL, python, R, etc
Proficiency working with wide array of commercial pharma data sets, including data sets such as IQVIA (or equivalent from different data vendor) XPONENT PlanTrak, DDD, LAAD (patient claims data), and internally generated sales / marketing data (e.g. field call data from CRM)
Experience with advanced analytics and machine learning modelling including time series modelling, XGBoost, predictive modelling, regression, and other statistical modelling algorithms
Experience working on products competing in large, complex markets and experience across both retail & hospital products
Strong analytical and business acumen: intellectual curiosity, motivation and ability to structure problems, diagnose issues and triangulate with multiple approaches while keeping sight of the 'big picture'
Experience working with senior leadership to support insights generation and communication, advanced analytics & modeling, and commercial launch planning
Ability to quickly and thoughtfully adapt to new and evolving business and planning needs
Benefits
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Recent News
MarketScreener
2026-01-03
The Motley Fool
2025-12-30
The Motley Fool
2025-12-28
Company data provided by crunchbase